1. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280(17):1497–503.
2. Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012;2(4):a007161.
3. Williams I, Churchill D, Anderson J, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (updated November 2013. All changed text is cast in yellow highlight.). 2014. http://www.bhiva.org/documents/Guidelines/Treatment/2012/hiv_v15_is1_Rev.pdf . Accessed 16 Oct 2014.
4. European AIDS Clinical Society. Guidelines version 7.02. 2014. http://eacsociety.org/Portals/0/140601_EACS%20EN7.02.pdf . Accessed 16 Oct 2014.
5. US Department of Health and Human Services panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2014. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf . Accessed 16 Oct 2014.